A metal chelator, diphenylthiocarbazone, induces apoptosis in acute promyelocytic leukemia (APL) cells mediated by a caspase-dependent pathway without a modulation of retinoic acid signaling pathways

Leuk Res. 2002 Jul;26(7):661-8. doi: 10.1016/s0145-2126(01)00186-2.

Abstract

A metal chelator, diphenylthiocarbazone (dithizone), has been reported to induce differentiation and apoptosis of the human myeloid leukemia cell line HL-60, however, very little is known about the mechanism of dithizone-induced apoptosis. Here, we report for the first time that dithizone can induce inhibition of cellular growth of retinoic acid (RA)-sensitive NB4 and RA-resistant UF-1 APL cells via induction of apoptosis but not differentiation. Treatment of NB4 cells with dithizone markedly-induced apoptosis, which was associated with the loss of mitochondrial transmembrane potentials (Delta Psi(m)) and activation of caspase-3 and -9. Further investigation of the RA-resistant UF-1 APL cells showed that dithizone-induced apoptosis to a lesser extent. However, neither dithizone alone nor in combination with all-trans RA induced the expression of myeloid differentiation antigen CD11b. Concomitantly, the degradation of PML/RARalpha fusion protein was not observed after treatment with dithizone alone, and the degradation was not enhanced by the combination of dithizone and all-trans RA. We conclude that dithizone, a metal chelator, induced apoptosis without differentiation in APL cells in association with Delta Psi(m) collapse and caspase-3 and -9 activation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Apoptosis / drug effects*
  • Caspase 3
  • Caspase 9
  • Caspase Inhibitors
  • Caspases / physiology*
  • Cell Differentiation / drug effects
  • Chelating Agents / pharmacology*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dithizone / pharmacology*
  • Drug Interactions
  • Drug Resistance, Neoplasm
  • Enzyme Activation / drug effects
  • Intracellular Membranes / drug effects
  • Leukemia, Promyelocytic, Acute / pathology*
  • Macrophage-1 Antigen / biosynthesis
  • Membrane Potentials / drug effects
  • Mitochondria / drug effects
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / physiology*
  • Neoplastic Stem Cells / cytology
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / enzymology
  • Oncogene Proteins, Fusion / physiology
  • Signal Transduction / drug effects*
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured / cytology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / enzymology

Substances

  • Amino Acid Chloromethyl Ketones
  • Caspase Inhibitors
  • Chelating Agents
  • Cysteine Proteinase Inhibitors
  • Macrophage-1 Antigen
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Tretinoin
  • Dithizone
  • CASP3 protein, human
  • CASP9 protein, human
  • Caspase 3
  • Caspase 9
  • Caspases